Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates

F Lotfipour1, S Abdollahi2, M Jelvehgari2

  • 1Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Drug Research
|December 6, 2013
PubMed

Insights

Antimicrobial vancomycin (VCM) nanoparticles showed reduced effectiveness against Enterococcus bacteria compared to VCM solution. This suggests challenges in nanoparticle drug delivery for treating resistant infections.

Area of Science:

  • Pharmacology
  • Materials Science
  • Microbiology

Background:

  • Nanoparticle (NP) formulations enhance antimicrobial agent activity.
  • Vancomycin (VCM) is a glycopeptide antibiotic effective against Gram-positive bacteria but poorly absorbed intestinally.
  • Enterococcus species are increasingly resistant to antibiotics and cause severe hospital-acquired infections.

Purpose of the Study:

  • To prepare vancomycin-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs).
  • To compare the antimicrobial efficacy of VCM-loaded PLGA NPs with VCM solution against clinical Enterococcus isolates.
  • To evaluate the effectiveness of VCM-loaded PLGA NPs against vancomycin-resistant Enterococcus.

Main Methods:

  • VCM-loaded PLGA NPs were fabricated using the W1/O/W2 solvent evaporation method.
  • Minimum Inhibitory Concentration (MIC) assays were performed to compare antimicrobial activity.
  • Antimicrobial effects were tested against both vancomycin-susceptible and vancomycin-resistant clinical Enterococcus isolates.

Main Results:

  • VCM-loaded PLGA NPs exhibited a significantly reduced antimicrobial effect compared to VCM solution.
  • The efficacy of VCM-loaded NPs against vancomycin-resistant Enterococcus was lower than against susceptible isolates.
  • Reduced in vitro antimicrobial activity may be due to slow VCM release from PLGA NPs caused by electrostatic interactions.

Conclusions:

  • Vancomycin-loaded PLGA nanoparticles demonstrate diminished antimicrobial activity in vitro.
  • The formulation may not be optimal for treating Enterococcus infections, particularly resistant strains.
  • Further research is needed to optimize NP formulations for improved antibiotic delivery and efficacy.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191